ORALLY DISINTEGRATING TABLET MELOXICAM FORMULATION WITH VARIATION CONCENTRATION OF AC-DI-SOL® AND KOLLIDON CL® AS SUPERDISINTEGRANT AGENT
Angi Nadya Bestari(1*), T.N. Saifullah Sulaiman(2), Abdul Rohman(3)
(1) Fakultas Farmasi, Universitas Gadjah Mada
(2) Fakultas Farmasi, Universitas Gadjah Mada
(3) Fakultas Farmasi, Universitas Gadjah Mada
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDFReferences
Allen, L.V., Popovich, N.G. dan Ansel, H.C. 2011, Ansel’s Dossage Forms and Drug Delivery Systems, 9th Ed., Lippinkott Williams and Wilkins, Philadelphia. Balasubrmaniam, J. 2009, Influence of Superdisintegrants on The Rate of Drug Dissolution from Oral Solid Dosage Forms, Pharmaceutical Technology, April. Bhowmik, D., Chiranjib, B., Krishnakanth, Pankaj and Chandira, R.M. 2009, Fast Dissolving Tablet: An Overview, Journal Chemical Pharmaceutics. Res, 1: 163-177. Departemen Kesehatan, 1979, Farmakope Indonesia, Edisi Ketiga, Jakarta, Departemen Kesehatan Republik Indonesia. Departemen Kesehatan, 1995, Farmakope Indonesia, Edisi IV, Jakarta, Departemen Kesehatan Republik Indonesia. Department of Health, 2009, British Pharmacopoiea, The Departement of Health, London. Goodman, G.A. 1997, The Pharmacological Basis of Therapeutic, pp 447-448, McGraw-Hill, New York, United States America. Gupta, A. and Dubey, P. K. 2012, Solubility Enhancement of Meloxicam and Formulation Development of Rapid Disintegrating Tablet of Meloxicam, International Journal of Pharmaceutical and Medicinal Sciences, 1: 1-20. Hansen, K.E. and Elliot, M. E. 2005, Osteoarthritis, Pharmacotherapy A Pathophysiological Approach. Jain, C. P. And Naruka, P. S. 2009, Formulation and Evaluation of Fast Dissolving Tablets of Valsartan, International Journal of Pharmacy and Pharmaceutical Sciences, 1: 219-221. Kibbe, A.H., 2009, Crospovidone, dalam Rowe, R.C, Sheskey, P.J., Quinn, M.E., (Eds.), Handbook of Pharmaceutical Excipients, 6th Edition, 208-209, Pharmaceutical Press and American Pharmacists Association, USA. Kim, H. and Lee, I. 2007, A Novel Drug Delivery System Design for Meloxicam, JPharm Pharmaceut Sci, 10 (3): 288-298. Kornblum, S. And Stopak, S.A. 2001, A New Tablet Disintegrating Agent: Crosslinked Polyvinyl Pyrrolidone, J Am Pharm Assoc, 41 (2): 229-272. Koseki, T., Onishi, H., Takahashi, Y., Uchida, M. and Machida, Y. 2008, Development of A Novel Fast Disintegrating Tablets by Direct Compression Using Sucrose Stearic Acid Ester as A Disintegration Accelerating Agent, Journal Chemical Pharmaceutics, 56 (10): 1.384-1.388. Kumar, G. P. and Nirmala, R. 2012, Fundamental Aspects of Superdisintegrants: a Concise Review, Journal of Global Pharma Technology, 4 (2), 1-12. Kundu, S. and Sahoo, P. K. 2008, Recent Trend in The Development of Orally Disintegration Tablet Technology, Pharma Times, 40 (4): 1-5. Manivannan, R. 2009, Oral Disintegrating Tablets: A Future Compaction, International Journal of Pharmaceutical Research and Development-Online, 10: 1-10. Obaidat, A. A., Khanfar, R. A. and Khawam, M. N. 2009, The Effect of β-Cyclodextrin on The Solubility and Dissolution Rate of Meloxicam and Investigation of The Driving Force for Complexation Using Molecular Modeling, J. Incl. Phenom. Macrocycl. Chem., 63: 273-279. Panigrahi R. and Behera, S. 2010, A Review of Fast Dissolving Tablets, Webmed Central, 1 (9): 117. Singh, J. and Singh, R. 2009, Optimization and Formulation of Orodispersible Tablets of Meloxicam, Tropical Journal of Pharmaceutical Research, 8 (2): 153-159. United States Pharmacopeial Convention, 2008, United States Pharmacopeaa 32, United States Pharmacopeial Convention, Maryland. Verma, R.K. and Garg, S. 2001, Current Status of Drug Delivery Technologies and Future Directions, Pharmaceutical Technology, 25: 9–10.
DOI: https://doi.org/10.22146/farmaseutik.v12i2.26454
Article Metrics
Abstract views : 6408 | views : 42459Refbacks
- There are currently no refbacks.